Abstract
Subcutaneous once-daily LY2963016 insulin glargine (LY insulin glargine) [Abasaglar (R) (EU); Basaglar (R) (USA)] has been approved in the EU as a bio......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
